Long-term survival after hormonal therapy for stage D prostatic cancer.
Hormonal therapy occasionally produces long-term survival of men with metastatic carcinoma of the prostate. To identify which patients will benefit for long intervals a retrospective analysis was done on 56 men with stage D carcinoma of the prostate treated between 1963 and 1968. Of this group 5 patients lived longer than 10 years. We were unable to identify clinical or pathologic characteristics that would have indicated which patients would have done well.
D000230:Adenocarcinoma / Q000628:therapy; D000328:Adult; D000368:Aged; D001859:Bone Neoplasms; D002369:Castration; D006801:Humans; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000401:mortality* / Q000628:therapy; D012189:Retrospective Studies; D013997:Time Factors